Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
🌎 Global
Global
United States
Australia
United Kingdom
Canada
India
China
Argentina
Austria
Bahrain
Bangladesh
Belgium
Bermuda
Botswana
Brazil
Bulgaria
Chile
Colombia
Croatia
Cyprus
Czech Republic
Denmark
Egypt
Estonia
Finland
France
Germany
Ghana
Greece
Hong Kong
Hungary
Iceland
Indonesia
Ireland
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kenya
Kuwait
Latvia
Lithuania
Luxembourg
Malawi
Malaysia
Malta
Mauritius
Mexico
Morocco
Namibia
Netherlands
New Zealand
Nigeria
Norway
Oman
Pakistan
Palestinian Authority
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russia
Saudi Arabia
Serbia
Singapore
Slovakia
Slovenia
South Africa
South Korea
Spain
Sri Lanka
Sweden
Switzerland
Taiwan
Tanzania
Thailand
Trinidad & Tobago
Tunisia
Turkey
Uganda
Ukraine
United Arab Emirates
Venezuela
Vietnam
Zambia
Zimbabwe
Create a narrative
Global Community
Our community narratives are driven by numbers and valuation.
Create a narrative
Community Investing Ideas
Global Weekly Picks
GXAI
Gaxos.ai
Sponsored
content by Gaxos.ai
JO
Jolt_Communications
Community Contributor
Gaxos.ai: Early-Stage AI Innovator in Gaming & Health
Key Takeaways Dual AI focus – Gaxos.ai builds AI-powered tools for game developers (via Unity integrations) and AI-driven health services under its RNK Health brand. First signs of commercial traction – After years of development, the company reported ~$194k in H1 2025 revenue, mainly from wellness pilot programs.
View narrative
US$2.21
FV
5.9% undervalued
intrinsic discount
119.00%
Revenue growth p.a.
Set Fair Value
1
users have liked this narrative
1
users have commented on this narrative
24
users have followed this narrative
Updated
narrative
Microsoft
PI
PicaCoder
Community Contributor
After the AI Party: A Sobering Look at Microsoft's Future
The world has been captivated by the artificial intelligence boom, and no company has ridden the wave of investor enthusiasm quite like Microsoft. Buoyed by its strategic partnership with OpenAI and the integration of AI across its product ecosystem, the company's valuation has soared to unprecedented heights.
View narrative
US$500.00
FV
1.4% overvalued
intrinsic discount
6.75%
Revenue growth p.a.
Set Fair Value
20
users have liked this narrative
9
users have commented on this narrative
25
users have followed this narrative
11 days ago
author updated this narrative
Amazon.com
ZW
Zwfis
Community Contributor
Amazon's Future Rises as Stock Price Falls: A Long-Term Investment Vision
Amazon is a stock I am very interested in right now especially with the recent price drops that it has been experiencing since its 2Q25 results. A summary of Amazon as stated by Fiscal.ai: "Amazon.com, Inc.
View narrative
US$234.75
FV
2.5% undervalued
intrinsic discount
13.60%
Revenue growth p.a.
Set Fair Value
18
users have liked this narrative
7
users have commented on this narrative
22
users have followed this narrative
New
narrative
Verve Group
TI
TibiT
Community Contributor
Verve Group: A Tale of Three Futures
Verve Group stands at a critical juncture. After a history of explosive growth, the company has been hit by significant operational headwinds, primarily the difficult and costly migration to a unified technology platform and unfavorable currency exchange rates.
View narrative
€4.02
FV
44.5% undervalued
intrinsic discount
8.50%
Revenue growth p.a.
Set Fair Value
3
users have liked this narrative
0
users have commented on this narrative
15
users have followed this narrative
Updated
narrative
All companies
Popular
Undervalued
Overvalued
Load previous narratives
Petroreconcavo
AN
AnalystHighTarget
Consensus Narrative from 12 Analysts
Digital Automation And Energy Security Will Reshape Brazil's Onshore Industry
Key Takeaways Innovative drilling, advanced recovery, and digitalization could unlock significant reserve growth, industry-leading margins, and profitability beyond current market expectations. Strong policy tailwinds, vertical integration, and a consolidation strategy may secure market dominance, resilient revenue, and transformative long-term growth opportunities.
View narrative
R$22.00
FV
42.0% undervalued
intrinsic discount
4.85%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Gland Pharma
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
Rapid GLP-1 Capacity Increase Will Erode Profit Margins
Key Takeaways Overexpansion of production capacity and slow commercial uptake risk suppressing profitability and pressuring margins over multiple years. Vulnerability to global protectionism, supply chain dependence, and slow innovation in advanced drug segments threaten long-term growth and financial stability.
View narrative
₹1.24k
FV
57.4% overvalued
intrinsic discount
14.23%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Sasol
AN
AnalystLowTarget
Consensus Narrative from 9 Analysts
Fossil Dependence Will Squeeze Margins Though Some Relief Will Emerge
Key Takeaways Global energy transition and tightening climate regulations threaten Sasol's fossil-fuel-based revenues, increase compliance costs, and raise risks of market restrictions. Persistent high emissions, intense competition, and balance sheet vulnerabilities increase exposure to earnings volatility and undermine profitability and future dividend stability.
View narrative
R70.00
FV
55.5% overvalued
intrinsic discount
-1.40%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
Aegis Logistics
AN
AnalystLowTarget
Consensus Narrative from 3 Analysts
Aggressive Expansion Will Spur Overcapacity And Margin Erosion
Key Takeaways Large-scale expansion risks asset underutilization and margin compression as the energy sector shifts towards renewables and customer demand patterns change. Heightened regulatory, competitive, and counterparty challenges threaten profitability, revenue stability, and long-term market share.
View narrative
₹620.00
FV
18.6% overvalued
intrinsic discount
6.81%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
New
narrative
Greggs
AN
AnalystLowTarget
Consensus Narrative from 12 Analysts
UK Quick-Service Saturation And Rising Regulation Will Undermine Viability
Key Takeaways Evolving consumer preferences and regulatory demands threaten revenue growth and profitability by increasing compliance costs and challenging Greggs' traditional product offerings. Market saturation, fierce competition, and rising input costs are capping expansion potential, compressing margins, and limiting earnings growth opportunities.
View narrative
UK£13.30
FV
22.6% overvalued
intrinsic discount
7.28%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Sharda Cropchem
AN
AnalystHighTarget
Consensus Narrative from 5 Analysts
Rising Global Food Demand Will Spur Sustainable Crop Protection
Key Takeaways Margin expansion and profitability are likely to exceed expectations due to high-margin regional growth and accelerated market expansion from pending registrations. Strong cash generation and an agile, asset-light model position Sharda to boost shareholder returns and capitalize rapidly on sustainability-driven market trends.
View narrative
₹1.26k
FV
23.7% undervalued
intrinsic discount
15.57%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Mega Lifesciences
AN
AnalystHighTarget
Consensus Narrative from 7 Analysts
Aging Populations And Emerging Markets Will Drive Wellness Demand
Key Takeaways Accelerated manufacturing expansion, robust product pipeline, and localization strategies position Mega Lifesciences for outperformance in topline growth and margin resilience. Early focus on prevention-oriented brands and proactive market adaptation may lead to dominant status and sustained earnings growth amid evolving health trends.
View narrative
฿39.00
FV
24.4% undervalued
intrinsic discount
6.76%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
1
users have followed this narrative
2 days ago
author updated this narrative
PageGroup
AN
AnalystHighTarget
Consensus Narrative from 10 Analysts
Global Talent Trends Will Expand Digital And Cross-Border Recruitment
Key Takeaways Strategic client partnerships, tech investment, and focus on senior roles position PageGroup for higher margins and outsized growth beyond market expectations. Emphasis on flexible staffing, AI-driven sector expansion, and globalization reduces volatility while boosting long-term earnings and market share.
View narrative
UK£4.50
FV
42.7% undervalued
intrinsic discount
4.68%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Vistry Group
AN
AnalystHighTarget
Consensus Narrative from 15 Analysts
UK Housing Shortage Will Unlock Secular Market Opportunities
Key Takeaways Vistry's unique Partnerships model and operational improvements position it to capture outsized growth, efficiency gains, and margin outperformance versus peers. Strategic relationships and early investment in sustainable building enable recurring revenue, improved earnings quality, and market share gains as housing demand and regulations intensify.
View narrative
UK£7.73
FV
16.4% undervalued
intrinsic discount
11.69%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
0
users have followed this narrative
2 days ago
author updated this narrative
Value any company in seconds
Popular companies